Join to View Full Profile
30 Prospect AveHackensack, NJ 07601
Dr. Mody is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Rowan University School of Osteopathic MedicineClass of 2024
Publications & Presentations
PubMed
- 1 citationsTirzepatide 10 and 15 mg vs semaglutide 2.0 mg: A long-term cost-effectiveness analysis in patients with type 2 diabetes in the United States.Reema Mody, William J Valentine, Meredith Hoog, Helen Sharland, Mark Belger
Journal of Managed Care & Specialty Pharmacy. 2024-02-03 - Cost per Patient Achieving Treatment Targets and Number Needed to Treat with Tirzepatide Versus Semaglutide 1 mg in Patients with Type 2 Diabetes in the United States.Reema R Mody, Kellie L Meyer, Jennifer M Ward, Ken B O'Day
Diabetes Therapy. 2023-12-01 - 9 citationsLong-term cost-effectiveness analysis of tirzepatide versus semaglutide 1.0 mg for the management of type 2 diabetes in the United States.William J Valentine, Meredith Hoog, Reema Mody, Mark Belger, Richard Pollock
Diabetes, Obesity & Metabolism. 2023-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
